Managing HBV and HCV Infection Pre- and Post-liver Transplant

被引：1
|
作者：
Kumar, Naveen [1 ]
Choudhary, Narendra S. [2 ]
机构：
[1] Narayana Hosp Delhi, Hepatol & Gastroenterol, Delhi, India
[2] Medanta Medicity, Hepatol, Sect 38, Gurgaon, Delhi Ncr, India
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2024年 / 14卷 / 02期
关键词：
HEPATITIS-B-VIRUS; TENOFOVIR DISOPROXIL FUMARATE; SUSTAINED VIROLOGICAL RESPONSE; SOFOSBUVIR PLUS RIBAVIRIN; ACTING ANTIVIRAL THERAPY; C VIRUS; IMMUNE GLOBULIN; PEGYLATED-INTERFERON; OPEN-LABEL; PROPHYLAXIS WITHDRAWAL;
D O I：
10.1016/j.jceh.2023.09.008
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatitis B and C are common causes of end-stage liver disease and etiologies of liver transplantation. It is important to prevent recurrence in cases of hepatitis B. Nucleos(t)ide analogs are the mainstay of HBV treatment before (in patients with decompensated cirrhosis) and after liver transplantation. After the introduction of direct-acting antivirals, the treatment of HCV has become considerably easy. In patients with advanced HCV-related cirrhosis, it is better to do transplantation first and treat them after liver transplantation. The sustained virological response rates have improved from 8 to 50% in the interferon era to 90% in the direct-acting antivirals era. In the current review, we discuss the treatment of HBV and HCV before and after liver transplantation. ( J CLIN EXP HEPATOL 2024;14:101287)
引用
收藏
页数：14
相关论文
共 50 条
  • [31] Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation
    Sclair, Seth N.
    Fiel, Maria Isabel
    Wu, Hai-Shan
    Doucette, John
    Aloman, Costica
    Schiano, Thomas D.
    CLINICAL TRANSPLANTATION, 2016, 30 (06) : 722 - 730
  • [32] Deep sequencing shows low-level oncogenic hepatitis B virus variants persists post-liver transplant despite potent anti-HBV prophylaxis
    Lau, K. C. K.
    Osiowy, C.
    Giles, E.
    Lusina, B.
    van Marle, G.
    Burak, K. W.
    Coffin, C. S.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (06) : 724 - 732
  • [33] Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1
    Lutchman, G.
    Nguyen, N. H.
    Chang, C. Y.
    Ahmed, A.
    Daugherty, T.
    Garcia, G.
    Kumari, R.
    Gupta, S.
    Doshi, D.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 738 - 746
  • [34] Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
    Vileret, Francois
    Lebosse, Fanny
    Radenne, Sylvie
    Samuel, Didier
    Roche, Bruno
    Mabrut, Jean-Yves
    Leroy, Vincent
    Pageaux, Georges-Philippe
    Anty, Rodolphe
    Thevenon, Sylvie
    Ahmed, Sinafa Si
    Hamilton, Aaron
    Heil, Marintha
    Scholtes, Caroline
    Levrero, Massimo
    Testoni, Barbara
    Zoulim, Fabien
    ECOGREFFE Study Grp
    JHEP REPORTS, 2023, 5 (06)
  • [35] Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis
    Cortesi, P. A.
    Mantovani, L. G.
    Ciaccio, A.
    Rota, M.
    Mazzarelli, C.
    Cesana, G.
    Strazzabosco, M.
    Belli, L. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (07) : 1817 - 1826
  • [36] Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    Ross, AS
    Bhan, AK
    Pascual, M
    Thiim, M
    Cosimi, AB
    Chung, RT
    CLINICAL TRANSPLANTATION, 2004, 18 (02) : 166 - 173
  • [37] The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation
    Tanaka, Tomohiro
    Benmousa, Ali
    Marquez, Max
    Therapondos, George
    Renner, Eberhard L.
    Lilly, Leslie B.
    CLINICAL TRANSPLANTATION, 2012, 26 (05) : E561 - E569
  • [38] The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients
    Sanghi, Vedha
    Romero-Marrero, Carlos
    Flocco, Gianina
    Graham, Rondell P.
    Abduljawad, Baraa
    Niyazi, Fadi
    Asfari, Mohammad M.
    Hashimoto, Koji
    Eghtesad, Bijan
    Menon, K. V. Narayanan
    Aucejo, Federico N.
    Lopez, Rocio
    Yerian, Lisa M.
    Allende, Daniela S.
    VIRCHOWS ARCHIV, 2022, 480 (02) : 335 - 347
  • [39] Study of liver function tests in HIV-infected patients, with or without co-infection of HBV or HCV
    Hashemy, Seyed Isaac
    Rad, Robabeh Omidian
    Riazi, Zahra
    Hadi, Sadeghian Mohamamd
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S126 - S127
  • [40] Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis
    Liao, Haotian
    Tan, Ping
    Zhu, Zexin
    Yan, Xiaokai
    Huang, Jiwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (03) : 262 - 271
12345